Encompass Health Co. (NYSE:EHC) Shares Sold by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC trimmed its position in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 38.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 67,128 shares of the company's stock after selling 41,883 shares during the quarter. Allspring Global Investments Holdings LLC owned approximately 0.07% of Encompass Health worth $6,487,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. UMB Bank n.a. increased its holdings in shares of Encompass Health by 387.7% during the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company's stock valued at $31,000 after purchasing an additional 252 shares in the last quarter. V Square Quantitative Management LLC increased its holdings in Encompass Health by 53.0% in the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company's stock worth $39,000 after acquiring an additional 140 shares in the last quarter. Oakworth Capital Inc. purchased a new stake in Encompass Health in the 2nd quarter worth $40,000. Benjamin F. Edwards & Company Inc. increased its holdings in Encompass Health by 58.9% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company's stock worth $46,000 after acquiring an additional 198 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new stake in Encompass Health in the 2nd quarter worth $58,000. 97.25% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

EHC has been the subject of several recent analyst reports. Royal Bank of Canada boosted their price target on shares of Encompass Health from $95.00 to $105.00 and gave the stock an "outperform" rating in a report on Thursday, September 26th. UBS Group upped their target price on shares of Encompass Health from $100.00 to $110.00 and gave the stock a "buy" rating in a report on Wednesday, September 25th. KeyCorp initiated coverage on shares of Encompass Health in a report on Friday, October 11th. They set an "overweight" rating and a $115.00 target price for the company. Leerink Partnrs raised shares of Encompass Health to a "strong-buy" rating in a report on Wednesday, July 10th. Finally, Barclays dropped their target price on shares of Encompass Health from $113.00 to $109.00 and set an "overweight" rating for the company in a report on Tuesday, August 6th. Eight investment analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Buy" and an average price target of $104.67.

Insider Buying and Selling at Encompass Health

In other Encompass Health news, CFO Douglas E. Coltharp sold 12,260 shares of the company's stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $86.34, for a total value of $1,058,528.40. Following the transaction, the chief financial officer now owns 136,227 shares of the company's stock, valued at $11,761,839.18. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 2.10% of the stock is currently owned by corporate insiders.

Encompass Health Trading Down 0.4 %

Shares of EHC stock traded down $0.37 on Monday, hitting $93.09. 1,279,158 shares of the stock traded hands, compared to its average volume of 627,938. The firm's 50-day moving average price is $93.58 and its two-hundred day moving average price is $88.31. The company has a debt-to-equity ratio of 1.08, a quick ratio of 1.35 and a current ratio of 1.35. The stock has a market capitalization of $9.37 billion, a PE ratio of 23.91, a PEG ratio of 1.45 and a beta of 0.88. Encompass Health Co. has a twelve month low of $59.57 and a twelve month high of $98.74.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings results on Monday, August 5th. The company reported $1.11 earnings per share for the quarter, beating the consensus estimate of $1.01 by $0.10. The firm had revenue of $1.30 billion for the quarter, compared to analysts' expectations of $1.30 billion. Encompass Health had a net margin of 7.88% and a return on equity of 17.83%. The company's revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.95 EPS. As a group, analysts anticipate that Encompass Health Co. will post 4.18 EPS for the current year.

Encompass Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be given a $0.17 dividend. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 dividend on an annualized basis and a yield of 0.73%. Encompass Health's payout ratio is currently 17.35%.

Encompass Health announced that its Board of Directors has initiated a stock buyback program on Wednesday, July 24th that allows the company to buyback $500.00 million in outstanding shares. This buyback authorization allows the company to buy up to 5.4% of its shares through open market purchases. Shares buyback programs are typically a sign that the company's board believes its shares are undervalued.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.